Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
View ORCID ProfileJoshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, Susan Strachan-Johnson, John F. Lindo, J. Peter Figueroa
doi: https://doi.org/10.1101/2022.09.20.22280173
Joshua J. Anzinger
aThe University of the West Indies, Kingston, Jamaica
bThe Global Virus Network Jamaica Affiliate, Kingston, Jamaica
cAbbott Pandemic Defense Coalition, The University of the West Indies, Mona, Jamaica
Suzette M. Cameron-McDermott
aThe University of the West Indies, Kingston, Jamaica
Yakima Z.R. Phillips
aThe University of the West Indies, Kingston, Jamaica
Leshawn Mendoza
dMinistry of Health and Wellness, Kingston, Jamaica
Mark Anderson
eAbbott Laboratories, Infectious Disease Research, Abbott Park, Illinois, United States of America
fAbbott Pandemic Defense Coalition, Abbott Park, Illinois, United States of America
Gavin Cloherty
eAbbott Laboratories, Infectious Disease Research, Abbott Park, Illinois, United States of America
fAbbott Pandemic Defense Coalition, Abbott Park, Illinois, United States of America
Susan Strachan-Johnson
dMinistry of Health and Wellness, Kingston, Jamaica
John F. Lindo
aThe University of the West Indies, Kingston, Jamaica
J. Peter Figueroa
aThe University of the West Indies, Kingston, Jamaica
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted September 21, 2022.
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
Joshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, Susan Strachan-Johnson, John F. Lindo, J. Peter Figueroa
medRxiv 2022.09.20.22280173; doi: https://doi.org/10.1101/2022.09.20.22280173
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
Joshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, Susan Strachan-Johnson, John F. Lindo, J. Peter Figueroa
medRxiv 2022.09.20.22280173; doi: https://doi.org/10.1101/2022.09.20.22280173
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12843)
- Forensic Medicine (12)
- Gastroenterology (838)
- Genetic and Genomic Medicine (4650)
- Geriatric Medicine (427)
- Health Economics (735)
- Health Informatics (2957)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (937)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4437)
- Nursing (239)
- Nutrition (653)
- Oncology (2308)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1204)
- Primary Care Research (506)
- Public and Global Health (7036)
- Radiology and Imaging (1557)
- Respiratory Medicine (926)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)